Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size was valued at USD 3665.8 million in 2023 and is forecast to a readjusted size of USD 6128.6 million by 2030 with a CAGR of 7.6% during review period.

Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics industry chain, the market status of Hospitals (Real Time PCR, DNA/RNA Purification), Ambulatory Surgical Centers (Real Time PCR, DNA/RNA Purification), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics.

Regionally, the report analyzes the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Real Time PCR, DNA/RNA Purification).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market.

Regional Analysis: The report involves examining the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics:
Company Analysis: Report covers individual Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).

Technology Analysis: Report covers specific technologies relevant to Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics. It assesses the current state, advancements, and potential future developments in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Real Time PCR
    DNA/RNA Purification

Market segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Diagnostic Centers

Market segment by players, this report covers
    Abbott Laboratories
    Atlas Genetics
    Cepheid
    Fluxergy
    Roche Diagnostics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with revenue, gross margin and global market share of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics from 2019 to 2024.
Chapter 3, the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics.
Chapter 13, to describe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics by Type
        1.3.1 Overview: Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type in 2023
        1.3.3 Real Time PCR
        1.3.4 DNA/RNA Purification
    1.4 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Application
        1.4.1 Overview: Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Ambulatory Surgical Centers
        1.4.4 Diagnostic Centers
    1.5 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size & Forecast
    1.6 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast by Region
        1.6.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region, (2019-2030)
        1.6.3 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)
        1.6.4 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)
        1.6.6 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Abbott Laboratories
        2.1.1 Abbott Laboratories Details
        2.1.2 Abbott Laboratories Major Business
        2.1.3 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.1.4 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Abbott Laboratories Recent Developments and Future Plans
    2.2 Atlas Genetics
        2.2.1 Atlas Genetics Details
        2.2.2 Atlas Genetics Major Business
        2.2.3 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.2.4 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Atlas Genetics Recent Developments and Future Plans
    2.3 Cepheid
        2.3.1 Cepheid Details
        2.3.2 Cepheid Major Business
        2.3.3 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.3.4 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Cepheid Recent Developments and Future Plans
    2.4 Fluxergy
        2.4.1 Fluxergy Details
        2.4.2 Fluxergy Major Business
        2.4.3 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.4.4 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Fluxergy Recent Developments and Future Plans
    2.5 Roche Diagnostics
        2.5.1 Roche Diagnostics Details
        2.5.2 Roche Diagnostics Major Business
        2.5.3 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.5.4 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Roche Diagnostics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics by Company Revenue
        3.2.2 Top 3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players Market Share in 2023
        3.2.3 Top 6 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players Market Share in 2023
    3.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Overall Company Footprint Analysis
        3.3.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Region Footprint
        3.3.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Company Product Type Footprint
        3.3.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2024)
    5.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    6.2 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    6.3 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
        6.3.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2030)
        6.3.2 United States Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        6.3.3 Canada Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        6.3.4 Mexico Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    7.2 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    7.3 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
        7.3.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2030)
        7.3.2 Germany Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        7.3.3 France Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        7.3.5 Russia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        7.3.6 Italy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2019-2030)
        8.3.2 China Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.3 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.4 South Korea Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.5 India Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        8.3.7 Australia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    9.2 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    9.3 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
        9.3.1 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2030)
        9.3.2 Brazil Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        9.3.3 Argentina Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2030)
        10.3.2 Turkey Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)
        10.3.4 UAE Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
    11.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
    11.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Industry Chain
    12.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Upstream Analysis
    12.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Midstream Analysis
    12.4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
    Table 6. Abbott Laboratories Major Business
    Table 7. Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 8. Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Abbott Laboratories Recent Developments and Future Plans
    Table 10. Atlas Genetics Company Information, Head Office, and Major Competitors
    Table 11. Atlas Genetics Major Business
    Table 12. Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 13. Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Atlas Genetics Recent Developments and Future Plans
    Table 15. Cepheid Company Information, Head Office, and Major Competitors
    Table 16. Cepheid Major Business
    Table 17. Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 18. Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Cepheid Recent Developments and Future Plans
    Table 20. Fluxergy Company Information, Head Office, and Major Competitors
    Table 21. Fluxergy Major Business
    Table 22. Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 23. Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Fluxergy Recent Developments and Future Plans
    Table 25. Roche Diagnostics Company Information, Head Office, and Major Competitors
    Table 26. Roche Diagnostics Major Business
    Table 27. Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 28. Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Roche Diagnostics Recent Developments and Future Plans
    Table 30. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) by Players (2019-2024)
    Table 31. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Players (2019-2024)
    Table 32. Breakdown of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 33. Market Position of Players in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 34. Head Office of Key Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players
    Table 35. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Company Product Type Footprint
    Table 36. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Company Product Application Footprint
    Table 37. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics New Market Entrants and Barriers to Market Entry
    Table 38. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Mergers, Acquisition, Agreements, and Collaborations
    Table 39. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (USD Million) by Type (2019-2024)
    Table 40. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Share by Type (2019-2024)
    Table 41. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Forecast by Type (2025-2030)
    Table 42. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024)
    Table 43. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Forecast by Application (2025-2030)
    Table 44. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 45. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 46. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 47. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 48. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 49. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 50. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 51. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 52. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 53. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 54. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 55. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 56. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 57. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 58. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 59. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 60. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 61. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
    Table 62. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 63. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 64. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 65. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 66. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 67. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 68. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 69. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 70. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 71. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 72. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 73. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 74. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Raw Material
    Table 75. Key Suppliers of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Raw Materials
List of Figures
    Figure 1. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Picture
    Figure 2. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type in 2023
    Figure 4. Real Time PCR
    Figure 5. DNA/RNA Purification
    Figure 6. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application in 2023
    Figure 8. Hospitals Picture
    Figure 9. Ambulatory Surgical Centers Picture
    Figure 10. Diagnostic Centers Picture
    Figure 11. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region in 2023
    Figure 16. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Players in 2023
    Figure 22. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share in 2023
    Figure 24. Global Top 6 Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share in 2023
    Figure 25. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Share by Type (2019-2024)
    Figure 26. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share Forecast by Type (2025-2030)
    Figure 27. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Share by Application (2019-2024)
    Figure 28. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share Forecast by Application (2025-2030)
    Figure 29. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 63. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
    Figure 64. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
    Figure 65. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics in 2023
    Figure 68. Manufacturing Process Analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
    Figure 69. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

Abbott Laboratories
Atlas Genetics
Cepheid
Fluxergy
Roche Diagnostics